Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Summary

Cytek Biosciences announced participation in the Morgan Stanley 19th Annual Global Healthcare Conference on September 14, 2021, at 2:00 p.m. PT. Interested parties can access the live and archived webcast through the company's Investors section of their website.

Cytek specializes in cell analysis solutions, utilizing its proprietary Full Spectrum Profiling™ (FSP™) technology for highly sensitive and multiplexed cell analysis. Their core products include the Aurora and Northern Lights™ systems, and they operate globally from their headquarters in Fremont, California.

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

Cytek’s management is scheduled to present on Tuesday, September 14^th, at 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: investors.cytekbio.com

About Cytek Biosciences

Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cytek’s FSP platform includes its core instruments, the Aurora and Northern Lights™ systems, its cell sorter, the Aurora CS, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe.

Other than Cytek’s Northern Lights CLC system, which is available for clinical use in China and the European Union, Cytek’s products are for research use only – not for use in diagnostic procedures or for clinical purposes.

Cytek, Full Spectrum Profiling, FSP and Northern Lights are trademarks or registered trademarks of Cytek Biosciences, Inc.

Investor Relations Contact:
Carrie Mendivil/Mary Kate McDonough
Gilmartin Group LLC
(518) 727-6380
investors@cytekbio.com 

Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com 

FAQ

When will Cytek Biosciences present at the Morgan Stanley Global Healthcare Conference?

Cytek Biosciences will present on September 14, 2021, at 2:00 p.m. Pacific Time.

How can I access the Cytek Biosciences conference presentation?

The presentation can be accessed live and archived on the 'Investors' section of Cytek's website.

What technology does Cytek Biosciences use for cell analysis?

Cytek utilizes Full Spectrum Profiling™ (FSP™) technology for high-resolution and high-sensitivity cell analysis.

Where is Cytek Biosciences based?

Cytek Biosciences is headquartered in Fremont, California.

Are Cytek's products for clinical use?

Except for the Northern Lights CLC system in China and the EU, Cytek's products are for research use only.